Dysregulated stem cell niches and altered lymphocyte recirculation cause B and T cell lymphopenia in WHIM syndrome September 23, 2022 x4pharmaceutic
Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variants September 12, 2022 x4pharmaceutic
Can we identify WHIM in infancy? Opportunities with the public newborn screening process June 1, 2022 x4pharmaceutic
Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature February 9, 2022 x4pharmaceutic
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome December 24, 2020 x4pharmaceutic
Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome January 1, 2020 x4pharmaceutic
WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure August 1, 2019 x4pharmaceutic
Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies May 1, 2019 x4pharmaceutic
